Brown Shipley & Co’s DexCom DXCM Stock Holding History

Brown Shipley & Co’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-135	Closed	-$8.48K	–	78
2026 Q1	$8.48K	Buy	+135	New	+$9.4K	0.01%	75

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Shipley & Co's DXCM Position: Q2 2026 in Review

Brown Shipley & Co sold out of DexCom (DXCM) in Q2 2026, closing a stake of 135 shares — an estimated $8.48K sold.

Brown Shipley & Co first reported a position in DXCM in Q1 2026 and held it in 1 quarter. The position peaked at $8.48K in Q1 2026. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Brown Shipley & Co reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
Brown Shipley & Co sold 135 DexCom shares in Q2 2026, an estimated $8.48K.
Brown Shipley & Co first reported a position in DexCom in Q1 2026 and held it in 1 quarter.
Brown Shipley & Co's DexCom position peaked at $8.48K in Q1 2026.
974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Brown Shipley & Co's 13F filing for Q2 2026, filed 14 Jul 2026.